Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV000660386 | SCV000782466 | pathogenic | Paget disease of bone 2, early-onset; Familial expansile osteolysis | 2016-06-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001852524 | SCV002153118 | pathogenic | not provided | 2021-07-26 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects TNFRSF11A function (PMID: 10615125, 21472776). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 208143). This variant is also known as 83dup18, 84dup18. This variant, c.45_62dup, results in the insertion of 6 amino acid(s) to the TNFRSF11A protein (p.Leu16_Leu21dup), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant has been observed in individuals with autosomal dominant familial expansile osteolysis (PMID: 10615125, 12568416, 17447113). It has also been observed to segregate with disease in related individuals. |
OMIM | RCV000190351 | SCV000243899 | pathogenic | Familial expansile osteolysis | 2007-01-01 | no assertion criteria provided | literature only |